These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21972551)

  • 41. Evolution and Vaccination of Influenza Virus.
    Lam HC; Bi X; Sreevatsan S; Boley D
    J Comput Biol; 2017 Aug; 24(8):787-798. PubMed ID: 28686463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Swine influenza viruses a North American perspective.
    Vincent AL; Ma W; Lager KM; Janke BH; Richt JA
    Adv Virus Res; 2008; 72():127-54. PubMed ID: 19081490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
    Qi X; Lu C
    Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.
    Ghedin E; Sengamalay NA; Shumway M; Zaborsky J; Feldblyum T; Subbu V; Spiro DJ; Sitz J; Koo H; Bolotov P; Dernovoy D; Tatusova T; Bao Y; St George K; Taylor J; Lipman DJ; Fraser CM; Taubenberger JK; Salzberg SL
    Nature; 2005 Oct; 437(7062):1162-6. PubMed ID: 16208317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of computational and recombinant technologies for developing novel influenza vaccines.
    Wong TM; Ross TM
    Expert Rev Vaccines; 2016; 15(1):41-51. PubMed ID: 26595182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of Antigenically Advanced Variants of Influenza Viruses.
    Neumann G; Fan S; Kawaoka Y
    Methods Mol Biol; 2018; 1836():461-486. PubMed ID: 30151587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
    de Jong JC; Smith DJ; Lapedes AS; Donatelli I; Campitelli L; Barigazzi G; Van Reeth K; Jones TC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2007 Apr; 81(8):4315-22. PubMed ID: 17287258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influenza pandemics of the 20th century.
    Kilbourne ED
    Emerg Infect Dis; 2006 Jan; 12(1):9-14. PubMed ID: 16494710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Building a Better Flu Vaccine.
    Woodland DL
    Viral Immunol; 2018 May; 31(4):277. PubMed ID: 29664695
    [No Abstract]   [Full Text] [Related]  

  • 51. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible correlation between low antigenic drift of A(H1N1) influenza viruses and induction of HI antibodies.
    Iorio AM; Zei T; Neri M; Alatri A
    Eur J Epidemiol; 1996 Dec; 12(6):589-94. PubMed ID: 8982618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types.
    Recker M; Pybus OG; Nee S; Gupta S
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7711-6. PubMed ID: 17460037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequence-based antigenic change prediction by a sparse learning method incorporating co-evolutionary information.
    Yang J; Zhang T; Wan XF
    PLoS One; 2014; 9(9):e106660. PubMed ID: 25188236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic drift and variability of influenza viruses.
    Schweiger B; Zadow I; Heckler R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):133-8. PubMed ID: 12458347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
    Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
    [No Abstract]   [Full Text] [Related]  

  • 58. Influenza vaccines: challenges and solutions.
    Houser K; Subbarao K
    Cell Host Microbe; 2015 Mar; 17(3):295-300. PubMed ID: 25766291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Ge F; Li X; Ju H; Yang D; Liu J; Qi X; Wang J; Yang X; Qiu Y; Liu P; Zhou J
    Arch Virol; 2016 Jun; 161(6):1437-45. PubMed ID: 26935915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains.
    Pyhälä R; Ikonen N; Haanpää M; Kinnunen L
    Arch Virol; 1996; 141(6):1033-46. PubMed ID: 8712921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.